A gene expression signature predicting the recurrence of tamoxifen-treated primary breast cancer. - - GEO DataSets

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from PMC

A gene expression signature predicting the recurrence of tamoxifen-treated primary breast cancer.

(Submitter supplied) A 36-gene classifier was constructed through expression profiling of 132 tumors from tamoxifen-treated patients using 70-mer oligonucleotide microarrays. The robustness of the signature was demonstrated using expression data from 83 independent tumors. The 36-gene signature was (i) more efficient to predict disease-free survival than the traditional histo-pathological prognostic factors, (ii) as effective as the Nottingham Prognostic Index or the "Adjuvant!" software, and (iii) the only independent prognostic factor. more...

Organism:: Homo sapiens

Type:: Expression profiling by array

Platform:: GPL5049
155 Samples

Download data: GPR, TXT

Series

Accession:: GSE9893

ID:: 200009893

PubMed Full text in PMC Similar studies Analyze with GEO2R

Supplemental Content

GEO DataSets

Functional Genomics Studies

Result Filters

Send to:

Links from PMC

Supplemental Content

Related information

Important Links

Recent activity